stars 1 stars 2 stars 3

Phagenyx® is the first and only clinically validated neuromodulation system that utilizes pharyngeal electrical stimulation (PES) to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia. Supported by 30+ publications and designed for real-world care, Phagenyx enables early intervention, resulting in a 6-day faster return to oral nutrition, >2x improvement in swallowing safety, and 8 fewer days in the hospital.

Phagenesis Ltd Questions

The Phagenesis Ltd annual revenue was $7.3 million in 2026.

Conor Mulrooney is the COO of Phagenesis Ltd.

60 people are employed at Phagenesis Ltd.

The NAICS codes for Phagenesis Ltd are [33, 339].

The SIC codes for Phagenesis Ltd are [38, 384].

Top Phagenesis Ltd Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users